Munich, Germany

Hermann Kasparek

This inventor holds 1 USPTO granted patent. Top assignee: Solco Basel Ag. Active years: 1977.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hermann Kasparek: Innovator in Therapeutic Ureas

Introduction

Hermann Kasparek is a notable inventor based in Munich, Germany. He has made significant contributions to the field of therapeutically effective compounds, particularly focusing on N-substituted ureas. His work has implications for various therapeutic applications, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Hermann Kasparek holds a patent for "Therapeutically effective N-substituted ureas." This patent describes N-mono-substituted ureas represented by a specific chemical structure, wherein R can be hydrogen, hydroxyl, or thiol, R1 can be hydrogen, methyl, or ethyl, and n can be 1, 2, 3, or 4. These compounds exhibit therapeutic properties, highlighting their potential in medical treatments.

Career Highlights

Throughout his career, Hermann has been associated with Solco Basel AG, where he has contributed to the development of innovative therapeutic solutions. His work has been instrumental in advancing the understanding and application of N-substituted ureas in medicine.

Collaborations

Hermann has collaborated with notable colleagues, including Karl-Heinz Jaeger and Willy Herbrand, who is now deceased. These collaborations have enriched his research and contributed to the success of his innovative projects.

Conclusion

Hermann Kasparek's contributions to the field of therapeutically effective compounds underscore his role as a significant inventor. His patent on N-substituted ureas reflects his commitment to innovation in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…